Editas Medicine
What If You Could Repair Broken Genes?
178 employees · est. 2013 · Cambridge, United States
HuidaGene Therapeutics
辉大，给患者回答 | Answering the Patients！
27 employees · est. 2018 · Shanghai, China
Editas Medicine is the older company (2013 vs 2018); Editas Medicine is the larger of the two.
Side-by-Side Comparison
| Metric | Editas Medicine | HuidaGene Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2018 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Shanghai, China |
| Employees | ||
| Employees | 178 larger | 27 |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Series C |
| Total Funding | ||
| Total Funding | $1.03B | $100.00M |
| Funding Rounds | ||
| Funding Rounds | 9 | 2 |
| Services | ||
| Services | CRISPR Gene Editing Research, Development of Genomic Medicines, Clinical Trials and Pipeline Development, Manufacturing of Therapeutic Solutions | Gene Editing, Research and Development, CRISPR-cas12 and CRISPR-cas13 Technologies, Scientific Presentations, Manufacturing Capabilities |
| Target Customers | ||
| Target Customers | Patients with Serious Diseases, Healthcare Providers, Medical Research Institutions, Biopharmaceutical Industry | Healthcare Providers, Biopharmaceutical Companies, Researchers in Genetic Medicine, Patients with Genetic Disorders |
| Taxonomy | ||
| Taxonomy | Genome Editing, CRISPR/Cas9, CRISPR/Cas12a, Clinical Stage Biotech, Genomic Medicines, Precision Medicine, Gene Therapy, Genetic Disease Treatment, Blood Diseases, Sickle Cell Disease, Rare Diseases, Beta Thalassemia, Hematopoietic Stem Cells, In Vivo Editing, Cardiovascular Disease | CRISPR-based Gene Editing, Gene Therapy, Genomic Medicine, Clinical-stage Biotechnology, Ophthalmology Therapeutics, Otology Therapeutics, Myology Therapeutics, Neurology Therapeutics, Single-gene Disorders, Neurodegenerative Diseases, R&D In Gene Editing, Preclinical Therapeutic Programs, Disease Cause Repair, Biotechnology Innovation, Global Patient Care |
| Website | ||
| Website | editasmedicine.com | huidagene.com |
About Editas Medicine
Editas Medicine, founded in 2013 and headquartered in the United States, is a clinical-stage genome editing company at the forefront of leveraging CRISPR/Cas9 and CRISPR/Cas12a systems for medical innovation. Their ambition is encapsulated in their slogan, "What If You Could Repair Broken Genes?", w...
About HuidaGene Therapeutics
HuidaGene Therapeutics is a dynamic player in the biotech industry, established in 2018 and headquartered in China, with operations also in New Jersey. The company is at the forefront of genomic medicine, pioneering CRISPR-based gene-editing tools that promise transformative treatments for condition...
We will tell you when either one moves
BounceWatch watches Editas Medicine and HuidaGene Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Editas Medicine and HuidaGene Therapeutics — by email.
Frequently Asked Questions
Compare Editas Medicine with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Editas Medicine on 9 Jun 2026, and HuidaGene Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
